ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways

Wang, Gang; Chen, Kai; Ma, Chao; Wang, Chao; Chen, Delong; He, Jianbo; Liu, Yuhao; Jiang, Tao; Yuan, Jinbo; Chen, Leilei; He, Wei*; Xu, Jiake*广州中医药大学; 1; jk
Journal of Cellular Physiology2022-3DOI: 10.1002/jcp.30642
8被引10阅读
引用收藏
分享

摘要

Excessive activity of osteoclasts contributes to skeletal diseases such as osteoporosis and osteolysis. However, current drugs targeting osteoclast have various deficiencies, placing natural compounds as substitutions of great potential. Roburic acid (RA) is a triterpenoid exacted from Radix Gentianae Macrophyllae, which exhibits inhibitory effects on inflammation and oxidation. By employing an in vitro osteoclastogenesis model, this study investigates the effects and mechanisms of RA on intracellular signaling induced by receptor activator of nuclear factor-kappa B ligand (RANKL). As expected, RA at a concentration scope from 1 to 10 mu M dampened the osteoclast differentiation of bone marrow macrophages (BMMs) but without cell toxicity. Interestingly, RA showed no effect on osteoblastogenesis in vitro. Furthermore, RA mitigated F-actin ring formation, hydroxyapatite resorption, and gene expression in osteoclasts. Mechanistically, RA suppressed TNF receptor-associated factor 6 (TRAF6), the crucial adaptor protein following RANKL-RANK binding. On the one hand, RA downregulated the nuclear factor-kappa B (NF-kappa B) activity, extracellular regulated protein kinases (ERK) phosphorylation, and calcium oscillations. On the other hand, RA upregulated the antioxidative response element (ARE) response and the protein expression of heme oxygenase (HO)-1. These upstream alterations eventually led to the suppression of the nuclear factor of activated T cells 1 (NFATc1) activity and the expression of proteins involved in osteoclastogenesis and bone resorption. Furthermore, by using an ovariectomized (OVX) mice model, RA was found to have therapeutic effects against bone loss. On account of these findings, RA could be used to restrain osteoclasts for treating osteoporosis and other osteolytic diseases.

学科与关键词

关键词
osteoclastRANKLroburic acidTRAF6
相关
加载中…
  • A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
    Hong, Guoju; Chen, Zhenqiu; Han, Xiaorui; Zhou, Lin; Pang, Fengxiang; Wu, Rishana; Shen, Yingshan; He, Xiaoming; Hong, Zhinan; Li, Ziqi; He, Wei; Wei, Qiushi*Clinical and Translational Medicine, 2021, 11(5): e392.被引 31
  • Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
    Hong, Guoju; Zhou, Lin; Han, Xiaorui; Sun, Ping; Chen, Zhenqiu; He, Wei; Tickner, Jennifer; Chen, Leilei*; Shi, Xuguang*; Xu, Jiake*Frontiers in Pharmacology, 2020, 11: 331.被引 19
  • Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
    Wang, Gang; Ma, Chao; Chen, Kai; Wang, Ziyi; Qiu, Heng; Chen, Delong; He, Jianbo; Zhang, Cheng; Guo, Ding; Lai, Boyong; Zhang, Shuangxiao; Huang, Linfeng; Yang, Fan; Yuan, Jinbo; Chen, Leilei*; He, Wei*; Xu, Jiake*Frontiers in Pharmacology, 2022, 12: 810322.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular Physiology
发表日期
2022-03
卷期
第 237 卷, 第 3 期
页码
1790-1803
DOI
10.1002/jcp.30642
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Visiting Program for Graduate Students [20172101024]; Australian National Health and Medical Research Council [NHMRC, APP1107828, APP1127156, APP1163933]

作者

  • W

    Wang, Gang (第一作者)

    1 · guangzhou univ chinese med

  • C

    Chen, Kai

查看全部 12 位作者收起作者
  • M

    Ma, Chao

    guangzhou univ chinese med

  • W

    Wang, Chao

  • C

    Chen, Delong

  • H

    He, Jianbo

    2 · guangzhou univ chinese med

  • L

    Liu, Yuhao

    1 · guangzhou univ chinese med

  • J

    Jiang, Tao

  • Y

    Yuan, Jinbo

  • C

    Chen, Leilei

    guangzhou univ chinese med

  • H

    He, Wei (通讯)

    guangzhou univ chinese med

  • X

    Xu, Jiake (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417